Product introduction
Celbira Tablet is used in the treatment of cancer of the prostate gland. It may also be used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Celbira Tablet should be taken on an empty stomach, either one hour before or at least two hours after a meal. Taking it with food may increase the blood levels of Celbira Tablet, which may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.
The most common side effects of Celbira Tablet include vomiting, decreased potassium level in blood, edema (swelling), decreased white blood cell count, and fatigue. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Other than this, the yellowing of the skin, loss of appetite, shortness of breath, dark urine, and nausea can happen, which indicate some liver problems. Your doctor might check you for liver function, blood pressure, and the level of potassium in your blood.
Before taking Celbira Tablet, tell your doctor if you have high blood pressure, heart problems, liver or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medication, so let your doctor know about all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It may harm your baby. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You may be asked to undergo regular monitoring of your blood glucose level while on treatment.
Uses of Celbira Tablet
- Prostate cancer
Benefits of Celbira Tablet
In Prostate cancer
Side effects of Celbira Tablet
Common side effects of Celbira
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
- Nausea
- Hot flashes
- Headache
- Increased glucose level in blood
How to use Celbira Tablet
How Celbira Tablet works
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
What if you forget to take Celbira Tablet?
Quick tips
- Celbira Tablet is usually taken with another medicine called prednisolone to reduce unwanted side effects.
- It should be taken on an empty stomach, either one hour before or at least two hours after a meal.
- Always use effective birth control measures to prevent pregnancy while taking this medicine.
- Your doctor may regularly monitor your liver function, blood pressure, and the level of potassium in your blood while you are having treatment with this medicine.
FAQs
How to take Celbira Tablet?
Can Celbira Tablet cure prostate cancer?
Is Celbira Tablet a chemotherapy drug?
Why do I need to take prednisolone with Celbira Tablet?
Does Celbira Tablet affect liver?
How frequently should the liver investigations be done?
References:-
- U.S. Food and Drug Administration (FDA)
- Doxorubicin Hydrochloride drug label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050467s078,050629s030lbl.pdf
- European Medicines Agency (EMA)
- Zytiga (brand name Abiraterone Acetate) EPAR: https://www.ema.europa.eu/en/medicines/human/EPAR/zytiga
- Abiraterone Krka (generic Abiraterone Acetate): https://www.ema.europa.eu/en/medicines/human/EPAR/abiraterone-krka
- National Institutes of Health (NIH)
- Doxorubicin definition from NCI: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/doxorubicin-hydrochloride
- Example research paper on doxorubicin: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018245/
- ClinicalTrials.gov
- Example clinical trial for Doxorubicin: https://clinicaltrials.gov/study/NCT00003212


Reviews
There are no reviews yet.